Steric stabilization of cationic liposomeeDNA (CLeDNA) complexes is required for in vivo applications such as gene therapy. PEGylation (PEG: poly(ethylene glycol)) of CLeDNA complexes by addition of PEG2000-lipids yields sterically stabilized nanoparticles but strongly reduces their gene delivery efficacy. PEGylation-induced weakening of the electrostatic binding of CLeDNA nanoparticles to cells (leading to reduced uptake) has been considered as a possible cause, but experimental results have been ambiguous. Using quantitative live-cell imaging in vitro, we have investigated cell attachment and uptake of PEGylated CLeDNA nanoparticles with and without a custom synthesized RGD-peptide grafted to the distal ends of PEG2000-lipids. The RGD-tagged nanoparticles exhibit strongly increased cellular attachment as well as uptake compared to nanoparticles without grafted peptide. Transfection efficiency of RGD-tagged PEGylated CLeDNA NPs increases by about an order of magnitude between NPs with low and high membrane charge density (s M ; the average charge per unit area of the membrane; controlled by the molar ratio of cationic to neutral lipid), even though imaging data show that uptake of RGD-tagged particles is only slightly enhanced by high s M . This suggests that endosomal escape and, as a result, transfection efficiency of RGD-tagged NPs is facilitated by high s M . We present a model describing the interactions between PEGylated CLeDNA nanoparticles and the anionic cell membrane which shows how the PEG grafting density and membrane charge density affect adhesion of nanoparticles to the cell surface.
Introduction
Driven by the promises of gene therapy, the field of research centered on delivery of exogenous nucleic acids into cells remains extremely active [1e11] . Of the over 1900 clinical trials in gene therapy, 5.5% employ strategies classified as lipofection [12, 13] . The current preference for viral vectors over synthetic vectors such as cationic lipids and polymers exists because viral vectors are more efficient for gene delivery in vivo. However, they suffer from a variety of issues, the most important of which are safety concerns [14e18] . Furthermore, the capacity of viral vectors is small and limited by their capsid size, while synthetic vectors are able to deliver very large pieces of DNA [19] . Another advantage of synthetic vectors is that they are less immunogenic because they lack viral capsid proteins. Commercial synthetic vectors with high transfection efficiencies are available for in vitro applications but the same success has not been achieved in vivo. The low transfection efficiency (TE; a measure of expression of the transfected gene) of synthetic vectors in vivo is due to the numerous biological and physico-chemical barriers that must be overcome in the process: protecting genetic material during circulation in the bloodstream, targeting it to the desired tissue, and then transferring it from the extracellular environment into the target cell, through the cytoplasm, and finally into the nucleus [20e22] .
Surface functionalization of synthetic vectors with an inert polymer such as poly(ethylene glycol) (PEG) sterically stabilizes them and can help them avoid macrophage removal and thus remain in circulation [23, 24] . This is essential to enable tissue targeting. However, PEGylation also reduces TE [25] . A possible cause of this is reduced electrostatic attraction between the PEGylated CLeDNA complex and the cell plasma membrane, resulting in inefficient uptake. Previous work investigating the uptake of PEGylated vectors has yielded ambiguous results [26e29], possibly because no systematic study of the impact of important compositional parameters was performed. A variety of ligands such as transferrin, epidermal growth factor or cell penetrating peptides has been used to target CLeDNA complexes to specific cells or increase their uptake by cells [30e33] . However, many of these approaches, such as noncovalent complexation, do not lend themselves well to systematic studies. CLeDNA NPs, on the other hand, allow a high degree of control over NP charge, membrane charge density, and PEG grafting density. We thus created a model system to investigate specific and nonspecific attachment and uptake of CLeDNA NPs by covalently grafting a linear RGD (arginineglycine-aspartic acid) peptide to their surface. To this end, we used a custom synthesized lipid with a GRGDSP-OH peptide tethered to dioleyl lipid tails via PEG2000 (see Fig. S2 in the Supplementary Material). RGD-peptides bind to integrin receptors on the cell surface and have found broad applications in drug delivery and bioengineering [34e36] . While the linear RGD-peptide employed in this work is a good model system, future applications will make use of cyclic RGD peptides which exhibit higher specificity and affinity. For example, certain cyclic RGD peptides are very effective tumor targeting ligands by virtue of their ability to selectively target a v b 3 and a v b 5 integrins [37] .
To quantify the efficiency of RGD-mediated uptake of CLeDNA complexes, we investigated the biophysical properties, in vitro transfection efficiency and biological activity of PEGylated CLeDNA NPs with and without RGD-tagging as well as of CLeDNA complexes without PEGylation. We also studied the effect of complex composition on electrostatic interactions between NPs and cells, by preparing complexes and NPs at both high and low membrane charge density (s M ) (by varying the ratio of neutral and cationic lipid) and varied lipid/DNA charge ratio (r). Membrane charge density is a key parameter governing the TE of lamellar CLeDNA complexes [20, 38] . We used quantitative live-cell imaging with particle tracking to assess the effect of RGD-tagging on the attachment and cellular uptake of CLeDNA NPs and measured TE to determine whether RGD-tagging can recover TE to the level of complexes without PEGylation and how this depends on s M .
Materials and methods

Materials
DOTAP, DOPC and DOPE-PEG2000 (referred to here as PEG2K-lipid) were purchased as solutions in chloroform from Avanti Polar Lipids (Alabaster, AL). The RGD-PEG2K-lipid contains a GRGDSP peptide (Gly-Arg-Gly-Asp-Ser-Pro-OH) covalently attached to the distal end of the PEG-chain of a custom PEG2000-lipid. It was synthesized via Fmoc solid phase synthesis, employing a lipid-PEG-acid building block in the final coupling step. The chemical structures of the lipids are shown in the Supplementary Material (Fig. S2) . TRITC-DHPE (N-(6-tetramethyl-rhodaminethiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphatidyl-ethanol-amine) was purchased from Invitrogen and has an excitation and emission maximum of 555 nm and 580 nm, respectively. The luciferase plasmid (pGL3) used in transfection experiments was purchased from Promega. The GFP-tubulin (Clontech) and pGL3 plasmids were propagated in Escherichia coli and purified using a Qiagen Plasmid Mega Prep Kit. For live-cell imaging studies, the pGL3 vector was labeled using the Mirus Bio Label IT Nucleic Acid Labeling Kit with Cy5 (excitation/emission maximum: 649 nm/670 nm) according to the manufacturer's protocol.
Liposome preparation
Lipid solutions in chloroform/methanol (3:1, v:v; for the RGD-PEG2K-lipid) or chloroform were combined at the desired molar ratio of lipids in glass vials. Lipid molar ratios of DOTAP/DOPC/PEG2K-lipid were 80/20ex/x for high-s M complexes and 30/70ex/x for low-s M complexes. To liposomes for live-cell imaging, 0.5 wt% (of total lipid) TRITC-DHPE lipid label were added. After mixing, the lipid solutions in organic solvent were dried, first by a stream of nitrogen and then in a vacuum for 12 h. The appropriate amount of sterile, high resistivity (18.2 MU cm) water to achieve a final concentration of 1 mM lipid was then added to the dried lipid films, and the resulting mixtures were incubated at 37 C for 16 h to form liposomes. Following this incubation, the liposome solutions were sonicated using a tip sonicator to form small unilamellar vesicles.
Cell culture and transfection
Mouse L-cells (ATCC number: CCL-1) were cultured in DMEM (Invitrogen) supplemented with 5% fetal bovine serum (HyClone) and 1% Penicillin/Streptomycin (Invitrogen). Cells were kept at 37 C in a humidified atmosphere containing 5% CO 2 and were reseeded every 72 h to maintain subconfluency. For transfection studies, cells were seeded in 24 well-plates such that confluency at transfection was 60e80%.
CLeDNA complexes were formed by diluting 1 mg of DNA and the appropriate amount of liposome solution to 250 mL each with Optimem (Invitrogen) and mixing.
Complexes were incubated for 20 min at room temperature before addition to cells.
Cells were washed once with PBS and then incubated with 200 mL of complex suspension (0.4 mg of DNA per well) for 6 h. After 6 h, the transfection medium was removed, and cells were rinsed once with PBS and then incubated in supplemented DMEM for 18 h. Cells were harvested in 150 mL of Passive Lysis Buffer (Promega) and subjected to one freezeethaw cycle. Luciferase expression was measured using a PerkineElmer 1420 Victor3 V multilabel counter following the assay manufacturer's (Promega) instructions. TE results are normalized to total cellular protein as measured by a Bradford Assay (BioRad). Data points represent an average of two measurements with error bars showing the standard deviation. All experiments were performed at least two times to ensure reproducibility.
Dynamic light scattering and zeta potential
The size and effective charge measurement of CLeDNA complexes and nanoparticles (NPs) was measured using a Malvern Nanosizer ZS (Fig. 1D, E) or Brookhaven Goniometer Light Scattering system ( Fig. 2A) . CLeDNA particles were prepared in light-scattering vials at the same concentration used in the transfection assay. A total of 2 mg of DNA and the appropriate amount of liposome (to achieve the desired lipid/DNA charge ratio) were mixed in 1 mL of the appropriate buffer and incubated at room temperature for 20 min. Dynamic light scattering was performed in both DMEM and high resistivity water as indicated below. Plots show the zaverage diameter. All zeta potential measurements were performed in high resistivity water. All data points for dynamic light scattering and zeta potential are the average of two measurements performed on the same sample. Error bars show the standard deviation.
Cyro-electron microscopy
CLeDNA complexes (lipid molar ratios of DOTAP/DOPC ¼ 80/20 and DOTAP/ DOPC/PEG2K-lipid ¼ 80/15/5) were formed in 50 mM NaCl at a lipid/DNA charge ratio of r ¼ 10 and a final DNA concentration of 3 mg/mL from a 30 mM liposome stock solution. The sample containing 5 mol% PEG2K-lipid was centrifuged at 5000 rpm for 15 min after mixing. Samples were preserved in vitrified ice supported by holey carbon films on 400-mesh copper grids. Each sample was prepared by applying a 3 mL drop of sample suspension to a freshly plasma cleaned grid, blotting with filter paper, and immediately proceeding with vitrification in liquid ethane. Grids were stored under liquid nitrogen until transferred to the electron microscope for imaging. Electron microscopy was performed using an FEI Tecnai F20 electron microscope, operating at 120 keV equipped with a Gatan 4k Â 4k CCD camera. Vitreous ice grids were transferred into the electron microscope using a cryo-stage that maintains the grids at a temperature below À170 C. Images were acquired using the automated acquisition software Leginon [39] using settings of w2 mm defocus, electron dose of w20 e À /Å 2 , and a pixel size at the image of 0.22 nm.
Live cell imaging
Live-cell imaging was performed using dually labeled (see Materials) complexes at r ¼ 10. The concentration of CLeDNA NPs was the same as that used in the transfection assay. Cells were grown to 60% confluency on poly(L-lysine)-coated coverslips (22 mm) and maintained at 37 C using a Harvard Warner flow chamber (Harvard Apparatus Model #P2 and RC21-B). Images were taken on a Nikon Diaphot 300 using a Nikon 1.4 NA 60Â Plan Apo DIC Objective and Sensicam QE CCD. Brightfield images were captured at a magnification of 60Â in differential interference contract (DIC) mode. Fluorescent images are composed of two merged channels where one channel shows lipid (TRITC-DHPE) and the other DNA (Cy5). Images were analyzed using a Matlab routine that measured the intracellular spatial distribution of fluorescently labeled DNA. Data points and error bars represent the average and standard deviation of 10e20 representative cells. The Matlab routine first locates the cell boundary and nuclear membrane using the DIC image. Next, all intracellular fluorescent particles are located by fitting a 2D Gaussian to all fluorescent spots contained within the cell boundary. Finally, the closest distance to the nuclear membrane is measured and recorded for each intracellular particle.
Results
We measured the physico-chemical characteristics, transfection efficiency and intracellular trafficking for CLeDNA complexes without PEG2K-lipid (schematically shown in Fig. 1A) , with PEG2K-lipid (Fig. 1B) , or with RGD-PEG2K-lipid (Fig. 1C) . The chemical structures of the employed lipids (monovalent cationic DOTAP and neutral DOPC) and PEG2K-lipids are shown in the Supplementary Material. In addition to the surface functionalization, we varied the membrane charge density (s M ) and the lipid/DNA charge ratio (r) of the complexes. The membrane charge density is controlled by the molar ratio of cationic to neutral lipid. We chose 30 and 80 mol% DOTAP for low and high s M , respectively; less than 30 mol% DOTAP results in phase separation, while the TE of DOTAP/DOPCeDNA complexes is highest at the molar ratio of 80/20 (DOTAP/DOPC). The lipid/DNA charge ratio is an important parameter governing TE, and high TE requires r > 1, typically 3 r 15. (The onset of lipid toxicity places an upper limit on the usable range of r.) We varied r by adjusting the amount of lipid, keeping the amount of DNA that the cells were exposed to constant. For some experiments, we varied the mole fraction of PEG2K-lipid in the lipid mixture. Phase separation typically occurs at PEG2K-lipid contents above 10 mol%, which is why we did not investigate higher contents. To minimize nonspecific interactions, we used 10 mol% PEG2K-lipid for most of our experiments.
Biophysical characterization
We used dynamic light scattering to determine the particle size and zeta potential of CLeDNA complexes. Complexes prepared without PEG2K-lipid and at low charge ratios near the isoelectric point (r ¼ 2 and r ¼ 3) in cell culture medium are comparatively large (>300 nm) as soon as 20 min after mixing of cationic liposomes and DNA (Fig. 1D, E ). Their size increases over time: 24 h after mixing, these complexes have fused into mm-size aggregates. At higher r, the size of complexes without PEG2K-lipid is smaller and essentially stable over time. (Fig. 1E) , the size and stability of all complexes containing PEG2K-lipids is very similar. At low s M , small differences are visible.
Comparing NPs with 10% PEG2K-lipid and 10% RGD-PEG2K-lipid ( Fig. 1D ), RGD-functionalization of the distal end of the PEG chain results in slightly larger particles, especially at low r. Complexes without PEG2K-lipid exhibit the highest zeta potentials. For low-s M complexes, PEGylation by incorporation of PEG2K-lipid or RGD-PEG2K-lipid reduces their zeta potential strongly (from z41 mV to z23 mV) and also strongly reduces (to nearly zero) the increase of the zeta potential with r (filled black and red (in the web version) lines). PEGylation also strongly reduces the zeta potential of high-s M complexes, with PEG2K-lipid effecting a larger reduction than RGD-PEG2K-lipid. However, these complexes still show a strong increase of the zeta potential with r.
Cryo-TEM demonstrates that complexes formed without PEG2K-lipid form large aggregates in the presence of as little as 50 mM salt ( Fig. 1G ; the salt concentration (z150 mM) in cell culture medium is much larger). The lamellar structure of these complexes [40] is readily apparent. In contrast, PEGylation with only 5 mol% PEG2K-lipid allows CLeDNA complexes to remain as sub-200 nm, well-defined nanoparticles with an internal oligolamellar structure at the same salt concentration, even after extensive centrifugation (Fig. 1H) . These CLeDNA NPs coexist with unilamellar vesicles (Fig. 1H ).
Transfection efficiency
The dependence of the TE of high-s M CLeDNA complexes on the amount of incorporated PEG2K-lipid at two lipid/DNA charge ratios, r ¼ 3 and r ¼ 10 is shown in Fig. 2B . The high TE of complexes without PEGylation remains unchanged at 1 mol% PEG2K-lipid. TE then drops steeply for 5 mol% (which is near the transition from mushroom regime to brush regime) and further for 7 mol% to a very low level where it remains for 10 mol%. The schematic in Fig. 2C shows how surface grafted PEG2K in the mushroom regime has a Here, R g is the radius of gyration of the polymer chain, L is the brush length, and l g characterizes the grafting density. At a critical grafting density (z5 mol% PEG2K-lipid), the polymer chains transition from a coiled conformation (the "mushroom" conformation) to a more extended conformation (the "brush" conformation). globular conformation where the spacing between grafting points (l g ) is greater than the radius of gyration (R g ), while the brush regime occurs when l g < R G , which forces the PEG chains into an elongated conformation.
The transfection efficiencies (TE) of the three classes of CLeDNA complexes investigated in this work (Fig. 1AeC) as a function of r, for low and high s M are shown in Fig. 3 . PEGylation with PEG2K-lipid reduces the (low) TE of low-s M CLeDNA complexes by about an order of magnitude, independent of r (Fig. 3A , black squares and blue open triangles). The TE of RGD-tagged CLeDNA NPs at low s M increases with r, and for r ! 5, their TE matches that of the corresponding complexes without PEG2K-lipid (Fig. 3A , green triangles). High-s M DOTAP/DOPCeDNA complexes without PEG2K-lipid exhibit high TE which is comparable to that of commercial reagents. PEGylation reduces their TE by nearly three orders of magnitude (Fig. 3B) , with the reduction in TE decreasing slightly as 
Live-cell imaging of the uptake and trafficking of CLeDNA nanoparticles
We transfected cells with dually-labeled fluorescent CLeDNA NPs to directly observe particle uptake and intracellular motion. To quantitate the results from these experiments, we measured the spatial distribution of condensed fluorescent particles (Cy5 channel, i.e., the DNA label) using an automated Matlab routine [41] . Suh et al. proposed a similar analysis to determine the dominant types of particle motion at different spatial locations within the cytoplasm [42] . By measuring the distance between each NP and the nuclear membrane, we obtained the intracellular distribution of CLeDNA NPs as an ensemble average over many cells. Fig. 4 shows imaging results for low-s M CLeDNA NPs with and without RGD-tagging. Typical DIC and fluorescent images taken at the beginning (1 h after addition of complexes) and end (5 h after addition) of the incubation period of cells with CLeDNA complexes in our TE assay are shown in Fig. 4A and B . At the end of this incubation period, cells are washed with PBS and incubated in serumcontaining medium for 20e24 h before they are harvested and protein expression is measured (see Materials and Methods). At 1 h after incubation, particles rich in DNA are seen attached to filopodia, while the plasma membrane shows some staining by the fluorescent lipid label. This label (a fluorescent lipid) is simply mixed with the lipids of the complex and thus can label neighboring membranes via lipid exchange. A single intact PEGylated CLeDNA particle is observed inside the cell 5 h after incubation. Quantitative particle localization (Fig. 4C,D) confirms that uptake of low-s M CLeDNA NPs containing 10 mol% PEG2K-lipid is nearly zero (Fig. 4C, inset) . In contrast, cells incubated with RGD-tagged CLe DNA NPs (10 mol% RGD-PEG2K-lipid) show bright fluorescence along the outline of the cell (as well as some particles within it) 1 h after incubation and numerous fluorescently labeled particles within the cell perimeter 5 h after incubation. Quantitative particle localization shows that the RGD-tagged CLeDNA NPs accumulate in the perinuclear region of the cells (Fig. 4D) . The inset in Fig. 4C shows the average total number of NPs per cell: 5 h after complex addition, approximately 45 spots exhibiting bright fluorescence from the DNA label are observed in a single focal plane.
Live-cell imaging results for CLeDNA NPs at high s M are displayed in Fig. 5 . In contrast to their low-s M counterparts, high-s M CLeDNA NPs without RGD-tagging adhere to cells at early time points (t < 2 h), and a number of them are seen inside the cells 5 h after incubation (Fig. 5A, C) . Nonetheless, the total uptake of RGDtagged CLeDNA NPs is much higher (Fig. 5C, inset) , as observed for low-s M NPs. Comparing RGD-tagged NPs of high and low s M , the (Fig. 5B,D) .
Discussion
In this work, we aimed to investigate the importance of cell adhesion and uptake as a barrier to transfection by PEGylated CLe DNA complexes. In addition, we sought to investigate the effect of the important parameters s M and r (which are controlled by complex composition) on the uptake and in vitro TE of CLeDNA NPs. These parameters govern the strength of electrostatic, nonspecific interactions between CLeDNA NPs and cells. Thus, we not only compared PEGylated complexes with and without RGD-peptide functionalization, but also varied the molar ratio of cationic and neutral lipid and the lipid/DNA charge ratio. PEGylated complexes at low s M and high content of PEG2K-lipid, in particular, show negligible nonspecific interaction with cells and thus are an ideal system to investigate RGD-peptide-based specific interactions.
CLeDNA complexes prepared without PEG2K-lipid aggregate in salt-containing cell culture medium (Fig. 1D ,E,G) because the salt screens the electrostatic repulsion of the particles. The lower the zeta potential of these complexes, i.e., the lower their r and s M (Fig. 1F) , the smaller the electrostatic repulsion and thus the faster this aggregation occurs. Increasing r increases the zeta potential of complexes because at least part of the additional cationic lipid is incorporated into the complexes (a phenomenon called "overcharging" [43] ). The extent of this overcharging (and thus the zeta potential) increases with s M [43] . While complex aggregation is not necessarily detrimental for in vitro transfection, it is undesirable for in vivo applications, because large aggregates will not remain in circulation but accumulate in "first pass" organs such as the lungs and the liver. Preventing aggregation by increasing electrostatic repulsion (i.e., increasing r and s M ) is not a viable strategy to yield complexes for in vivo application because cationic particles are readily recognized by the complement system and removed from circulation [23] .
Incorporation of PEG2K-lipid or RGD-PEG2K-lipid into CLeDNA complexes strongly reduces their zeta potential, which is a measure of effective surface charge (Fig. 1F) . The zeta potential is defined as the electrostatic potential at the particle's slipping plane, a hypothetical radius where enclosed counterions are weakly bound to the particle. Exchanging neutral DOPC for the negatively charged PEG2K-lipids reduces the overall charge of the complexes and thus the zeta potential, but this effect is not large, especially at high s M .
The main reason for the measured decrease in zeta potential is an outward shift of the slipping plane due to the PEG/peptide-PEG shell surrounding each CLeDNA nanoparticle.
CLeDNA complexes prepared with PEG2K-lipid form nanoparticles that do not aggregate, regardless of charge ratio (Fig. 1D,E,G,H; Fig. 2A ), because the PEG2K-lipid confers a sterically stabilizing PEG-shell to the CLeDNA complex particles [25] . Adding an RGD-peptide to the distal end of a PEG2K-lipid does not impair its ability to sterically stabilize complexes (Fig. 1 D,E) . However, this stabilization against aggregation by attractive van der Waals interactions between particles does not necessarily imply that the attractive electrostatic interaction between nanoparticles and the plasma membrane is also screened. In fact, the uptake of PEGylated CLeDNA NPs increases with s M , whether or not they are tagged with RGD, and PEGylation even at 10 mol% is insufficient to fully inhibit the attachment and uptake of high-s M CLeDNA NPs (Fig. 5A,C) .
The drop of the TE of CLeDNA complexes with increasing content of PEG2K-lipid does not correlate with the extent of steric stabilization. Inclusion of 1 mol% PEG2K-lipid yields stable nanoparticles but leaves TE unaffected, and particle size and stabilization are the same for 5 and 7 mol% PEG2K-lipid, but their TE differs by about an order of magnitude. The drop in TE with PEG2K-lipid content does correlate, however, with a conformational transition of the PEG chains. At around 5 mol% PEG2K-lipid, full coverage of the complex with PEG chains in the mushroom conformation is achieved, corresponding to a drop in TE. However, the electrostatic interactions between the positively charged complexes and the negatively charged cell membrane are not fully suppressed, as evident from the relatively large increase of TE with r, i.e., with increasing zeta potential (effective surface charge) and therefore electrostatic interaction energy. At higher content of PEG2K-lipid, the PEG chains transition from the mushroom to the brush conformation (Fig. 2C) . At this transition, the range and strength of repulsive forces due to the grafted PEG chains increases, strongly reducing the electrostatic interaction between complexes and cells. This reduces TE to about the level of uncomplexed DNA and all but eliminates the increase of TE with r (Fig. 2B, 7 and 10% PEG2K-lipid).
TE decreases to near the baseline level of transfection (the level obtained with uncomplexed DNA) at the inclusion of 10 mol% PEG2K-lipid for both low and high s M CLeDNA NPs (Fig. 3) . This drop is most pronounced for complexes at high s M , which are highly efficient before PEGylation. Considering the main barriers to transfection, the observation that PEGylation sterically stabilizes CLeDNA complexes and reduces their zeta potential suggests two mechanisms that could cause the decrease in TE. One is a reduction in cell attachment and subsequent uptake, which is electrostatically mediated for CLeDNA complexes without PEGylation. The other is interference with endosomal escape, a step in the transfection process that requires fusion of the membranes of the complex and the endosome (also electrostatically mediated) and that has been shown to be the main barrier for lamellar complexes at low s M [20, 38] . Prior work quantifying the uptake of PEGylated CLeDNA complexes has yielded ambiguous results; according to some reports, uptake was inhibited [26, 27] , but it was found to be unchanged or even enhanced in others [28, 29] . Our data and model calculations (see below) point to an understanding that resolves this apparent contradiction: whether or not PEGylated complexes adhere to cells (which correlates with subsequent uptake in our experiments) depends on parameters such as PEG2K coverage, r, and s M , which are controlled by lipid choice and complex composition. In particular, s M is a key parameter affecting uptake and transfection efficiency of PEGylated CLeDNA complexes, as observed for complexes without PEGylation [20, 38] . At sufficiently high s M , electrostatic interactions "leak through" even at high PEG coverage. This promotes attachment to cells and endosomal escape (if less efficiently than for complexes without PEG-lipids), even as the PEGylation prevents aggregation of the CLeDNA NPs.
Hypothesizing that the reduced TE of PEGylated CLeDNA complexes is at least in part due to reduced attachment to cells and subsequent uptake, we prepared a PEG2K-lipid with an RGDpeptide at the distal end of the PEG chain (RGD-PEG2K-lipid; see the Supplementary Material for the chemical structure). The linear GRGDSP-peptide employed in the RGD-PEG2K-lipid binds to the ubiquitous integrin receptors on the cell surface. Thus, we sought to increase cell attachment, and potentially subsequent uptake, by substituting the RGD-PEG2K-lipid for the simple PEG2K-lipid (in other words, by RGD-tagging CLeDNA nanoparticles). (RGDtagging has been shown to improve the uptakednot only the cell attachmentdof metal nanoparticles and drugs [34] .) Low-s M CLeDNA NPs are an ideal system for studying the effect of RGD-tagging because their low surface charge prevents nonspecific adhesion to the cell surface ( Fig. 4A and C) . Live-cell imaging revealed that RGD-tagging indeed leads to efficient attachment of CLeDNA NPs to cells and their subsequent uptake (Fig. 4B  and D ). Low-s M CLeDNA NPs with and without RGD-tagging have nearly identical zeta potentials (the zeta potential of the RGDtagged NPs is in fact lower), strongly suggesting that the efficient attachment and subsequent uptake of the RGD-tagged NPs particles is solely attributable to ligand-receptor binding.
The fluorescence intensity of internalized particles 5 h after incubation is larger than, e.g., 1 h after incubation. This is likely due to fusion of endosomes containing fluorescently labeled nanoparticles, which would result in each fluorescent spot at 5 h corresponding to multiple CLeDNA particles within a single endosomal compartment.
At high s M , PEGylated CLeDNA NPs bind to the plasma membrane and are successfully uptaken, albeit both to a much smaller extent than their RGD-tagged counterparts (Fig. 5) . Increasing s M slightly improves the uptake of RGD-tagged CLeDNA NPs (z51 vs. z45 particles/cell at 5 h) but significantly improves the TE of RGD- [41, 44, 45] . The broad size distribution of non-PEGylated complexes prevents a direct comparison with NPs in live-cell imaging, but several lines of evidence suggest that the incomplete recovery of TE is indeed due to inefficient endosomal escape. Imaging results supporting this hypothesis are the increased intensity of fluorescent particles at later time points (see above), the observation of perinuclear accumulation of particles (observed for all particles taken up by the cells, likely as a result of endosomal trafficking), and the observation of modes of particle movement consistent with endosomal entrapment (see below). The fact that RGD-tagging fully recovers the TE of low-s M CLeDNA NPs is also consistent with the hypothesis. Previous work has shown that endosomal entrapment is the main barrier limiting TE for lamellar complexes at low s M (without PEGylation) [20, 38] and thus their level of TE can be achieved without efficient endosomal escape. Finally, we recently showed that the TE of PEGylated complexes is enhanced by employing an acid-labile PEG2K-lipid, which enhances fusion with endosomal membranes by shedding its PEGchains at low pH of late endosomes [41] . We analyzed the intracellular movement of RGD-tagged CLe DNA nanoparticles at high s M in live cells using particle tracking (see Supplementary Material for details). Analysis of the mean square displacement with time and labeling of microtubules with GFP-tubulin revealed both active transport of particles along microtubules and confined diffusion within a membrane-bounded compartment (Fig. S1 ). Both of these observations are consistent with endosomal entrapment of CLeDNA NPs. Particles entrapped in endosomes will show confined motion, and active transport via motor proteins is facilitated by specific interactions, suggesting that CLeDNA NPs undergoing such transport are enclosed within intact endosomes. Furthermore, another literature report has associated active transport of synthetic vectors with inefficient endosomal escape and low TE [46] .
Modeling of the interaction between PEGylated CLeDNA NPs and the cell membrane
We developed a model of the interaction between PEGylated CLeDNA NPs and the cell membrane to get a more detailed understanding of the parameters affecting this interaction and our experimental observations. For this model, we consider a charged, polymer-grafted sphere (as a model of the NP) approaching an oppositely-charged flat membrane (as a model of the plasma membrane). By calculating the free energy as a function of the distance between NP and plasma me8mbrane, we gain insight into how parameters such as s M and PEG grafting density affect the adhesion of CLeDNA NPs to cells. The total free energy (E T ) of interaction as a function of the distance D between the flat membrane and the outer edge of the polymer-grafted sphere comprises four separate terms of energy per unit area (E x ) and can be written as:
E E , E V , E H , and E S are the terms for electrostatic attraction, van der Waals attraction, hydration repulsion, and steric repulsion due to the grafted polymer shell, respectively. To compute the total free energy per particle, each of these terms is multiplied by a corresponding interaction area (A x ). The functional forms of the terms E x are:
The first term (Eq. (2)), which represents the electrostatic attraction, is the result of DebyeeHückel theory. Here, 1/k is the Debye screening length, which we calculated to be 0.65 nm at the salt concentration in DMEM (150 mM of 1:1 electrolytes and 2.5 mM of 2:1 electrolytes); s PM is the membrane charge density of the plasma membrane. The value of s PM used in the calculation shown in Fig. 6 is À2 Â 10 À3 e/Å 2 , which corresponds to a membrane containing 10 mol% anionic lipids. This is consistent with experimentally measured plasma membrane lipid compositions [47] . For the high values of r in our experiments, we assume that the surface charge density of the NP, s NP , is the same as that of the constituting lipid membrane, s M . The observation that the zeta potential approaches a saturation value as r increases (Fig. 1F) validates this assumption. For NPs at lower r (r < 5), the calculated s M is an upper limit for s NP . The surface charge density of the lipid membrane (s M ¼ total charge/total area) can be calculated as described in Ref. [48] , while also taking into account the negative charge of the PEG2K-lipids (see Fig. S2 for lipid chemical structures): The free energy per area of steric repulsion (Eq. (5)) in the brush regime (>5 mol% PEG2K-lipid) is strongly affected by two parameters: l g , the distance between grafting points and L, the brush length [52] (Fig. 2C ). Eq. (5) is a modified exponential approximation to a power law first proposed in Alexander de Gennes' theory [54] . The two modifications made to that power law are replacing L with L/2 and E with E/2. The rationale for these modifications is that the original power law and exponential approximation describe a scenario where both surfaces are grafted with polymer, whereas in our case only one is (the PEGylated CLeDNA NP). These modifications have been successfully used to model various systems where only one surface contains grafted polymer [55, 56] . When fit to experimental data, de Gennes' theory typically overestimates the repulsion between polymer grafted surfaces [58, 57] . In addition, accurate values for the headgroup size of the PEG2K-lipid are unavailable. Thus, we allowed l g to vary, within narrow boundaries. The value used in Fig. 6 is l g ¼ 4 nm, in reasonable agreement with the value (l g ¼ 3.02 nm) calculated by assuming equal headgroup size for all lipids as above (A headgroup ¼ 72 Å 2 ). The brush height L, which has been measured via X-ray scattering and surface force apparatus, was set to 6.6 nm [58, 59] . All four effective area terms A x were calculated using the Langbein approximation [52] . For a potential of the form w(r) ¼ Ce thickness; a local maximum located at z4.5 nm (reflecting the steric barrier arising from the grafted polymer), the height and location of with are determined by grafting density and brush length, respectively; and a second minimum at z6 nm. The first minimum corresponds to binding events where complexes stick to the cell surface and remain immobilized until endocytosis. It is only present for high s M . The second, shallow minimum, indicates weak binding of the particle, which we interpret to correspond to "bump and run" events. It is present for both high and low s M . These features are in excellent agreement with the live-cell imaging results which showed that high-s M CLeDNA NPs bind to and are taken up by cells (Fig. 5 ) while low-s M NPs do not attach (Fig. 4) .
Conclusions
PEGylation of CLeDNA complexes is mandatory for in vivo gene delivery applications but reduces transfection efficiency. Interestingly, steric stabilization of CLeDNA complexes against aggregation does not imply that cell attachment via electrostatic interaction between complexes and cells is inhibited, despite the fact that PEGylation severely reduces the effective surface potential. Uptake of PEGylated complexes (without RGD-tagging) is in fact significantly affected by s M : uptake of low-s M complexes is negligible, whereas high-s M complexes show some attachment and uptake. This explains seemingly inconsistent literature reports on the extent of uptake of PEGylated CLeDNA complexes. PEGylated CLe DNA complexes at low s M are an ideal model system to study targeting ligands and receptor-mediated uptake because for them the effects of specific interactions are not convoluted with those of nonspecific electrostatic attraction. RGD-tagging of PEGylated CLe DNA complexes strongly improves both attachment to cells and uptake, independent of s M . This fully recovers TE at low s M , where the TE of complexes without PEGylation is low and limited by endosomal escape. For high-s M complexes, TE recovery is only partial because of endosomal entrapment. Thus, the two main barriers increased by PEGylation are cellular uptake and endosomal escape. Future work to improve the TE of PEGylated CLeDNA complexes will need to combine tagging with RGD or similar targeting ligands with strategies to improve their endosomal escape, such as using acid-labile PEG-lipids.
